593 results on '"Asano, Taku"'
Search Results
2. Clinical impacts of CT-derived fractional flow reserve under insurance reimbursement: Results from multicenter, prospective registry
3. Artificial Intelligence–Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome
4. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials
5. Review of Bleeding and Thrombotic Risks Associated With Antithrombotic Therapy After Transcatheter Structural Heart Interventions
6. Abstract 14532: The Off-Hour Effect on Clinical Outcomes of ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock Patients Treated With Impella: Insight From Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD)
7. Five-Year Outcomes After Fractional Flow Reserve–Guided Deferral of Revascularization in Infarct-Related Artery Lesions
8. Clinical features and predictors of non-cardiac death in patients hospitalised for acute myocardial infarction: Insights from the Tokyo CCU network multicentre registry
9. A rare case of adenosine-sensitive atrial tachycardia originating at the mitral annulus’ anterior septum.
10. 10-Year Temporal Trends of In-Hospital Mortality and Emergency Percutaneous Coronary Intervention for Acute Myocardial Infarction
11. Efficacy of mitral annular velocity as an alternative marker of left ventricular global longitudinal strain to detect the risk of cancer therapy‐related cardiac disorders.
12. Middle-Power Middle-Duration versus High-Power Short-Duration Radiofrequency Ablation in Pulmonary Vein Isolation with Lesion Size Index-guided Strategies
13. Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN‐ICD/WCDstudy): Rationale and design of a prospective, multicenter, observational, comparative study
14. Use of PCR in the diagnosis of pericardial amebiasis: a case report and systematic review of the literature
15. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years
16. Clinical impacts of CT-derived fractional flow reserve under insurance reimbursement: Results from multicenter, prospective registry
17. Review of Bleeding and Thrombotic Risks Associated With Antithrombotic Therapy After Transcatheter Structural Heart Interventions
18. TCT-598 Hemodynamic Assessment of Suboptimal Percutaneous Coronary Intervention Outcomes Using Coronary Intravascular Imaging-Based Ultrasonic Flow Ratio and Optical Flow Ratio: Insights From ASET JAPAN Trial
19. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease
20. Five-Year Outcomes After Fractional Flow Reserve–Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry
21. Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics
22. Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study
23. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease
24. A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
25. Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD
26. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
27. Coronary calcification as a mechanism of plaque/media shrinkage in vessels treated with bioresorbable vascular scaffold: A multimodality intracoronary imaging study
28. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial
29. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds
30. Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction
31. A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging–Guided Percutaneous Coronary Intervention in Bifurcation Lesions
32. Impact of kidney volume on incidence of in-hospital kidney-related adverse outcomes in patients with acute heart failure
33. TCTAP A-046 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) In Brazil and Japan: Synergy Stent With Prasugrel Monotherapy Without Aspirin
34. Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)
35. The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure
36. CRT-100.33 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin
37. TCT-14 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) After PCI in Brazil and Japan: SYNERGY Stent With Prasugrel Monotherapy (10 mg or 3.75 mg)
38. Imaging assessment of bioresorbable vascular scaffolds
39. Single or dual antiplatelet therapy after PCI
40. Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography
41. The characteristic of an abnormal p-wave axis in patients with atrial fibrillation
42. Esophageal thermal lesions in radiofrequency ablation for atrial fibrillation: A prospective comparative study of thermal sensors
43. Impact of Coronary Remodeling on Fractional Flow Reserve
44. Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
45. Usefulness of Severe Cardiac Sympathetic Dysfunction to Predict the Occurrence of Rapid Atrial Fibrillation in Patients With Wolff-Parkinson-White Syndrome
46. Impact of the augmentation time ratio on direct measurement of central aortic pressure in the presence of coronary artery disease
47. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
48. Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials
49. Immediate discontinuation of ablation during pulmonary vein isolation remarkably decreases the incidence of esophageal thermal lesions even when using steerable sheaths
50. Long-term effectiveness of right septal pacing vs. right apical pacing in patients with atrioventricular block
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.